No abstract available
MeSH terms
-
Adult
-
Aged
-
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
-
Angiotensin-Converting Enzyme Inhibitors / adverse effects
-
Angiotensin-Converting Enzyme Inhibitors / pharmacology
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
-
Antihypertensive Agents / administration & dosage
-
Antihypertensive Agents / adverse effects
-
Antihypertensive Agents / pharmacology
-
Antihypertensive Agents / therapeutic use*
-
Arteries / drug effects
-
Arteries / physiology
-
Data Interpretation, Statistical
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / physiopathology
-
Elasticity
-
Endothelium, Vascular / drug effects*
-
Endothelium, Vascular / physiology
-
Female
-
Glycated Hemoglobin / analysis
-
Humans
-
Hypertension / complications
-
Hypertension / drug therapy
-
Male
-
Middle Aged
-
Ramipril / administration & dosage
-
Ramipril / adverse effects
-
Ramipril / pharmacology
-
Ramipril / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Treatment Outcome
-
Vasomotor System / drug effects
-
Vasomotor System / physiology
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Glycated Hemoglobin A
-
Ramipril